Daily FNArena News

Your Editor participated in Friday’s Afternoon Round Table on brr.com.au

The lead compound of Neuren Pharmaceuticals is being developed to treat brain injuries and with no current competition in the market Bell Potter sees upside from any success.

FNArena welcomes Peter Switzer from Switzer TV and the Switzer Super Report as a regular columnist/contributor from today onwards.

This week’s Tweets from Your Editor on Twitter.

Jonathan Barratt of Barratt’s Bulletin analyses the implications of suprisingly large copper stockpiles.

Oz Minerals has been downgraded by two stockbrokers following the release of a mixed quarterly production report.

DJ Carmichael has initiated coverage on Neptune Marine with a Spec Buy rating, viewing the stock as a turnaround story as new management grows a restructured business.

When it comes to Europe, nothing’s as easy as it looks, notes GaveKal.

GI Dynamics is developing the EndoBarrier product for use in treating type II diabetes and obesity and Bell Potter sees significant upside potential in the stock.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Brokers believe wheat crop estimates currently undervalue the level of spring rains, providing re-rating potential for some agri sector stocks.